Michael Burkes Brophy - Jan 31, 2025 Form 4 Insider Report for Natera, Inc. (NTRA)

Signature
/s/ Tami Chen, Attorney-in-Fact
Stock symbol
NTRA
Transactions as of
Jan 31, 2025
Transactions value $
-$7,763,862
Form type
4
Date filed
2/4/2025, 09:45 PM
Previous filing
Jan 31, 2025
Next filing
Mar 14, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Award +12.7K +12.49% 115K Jan 31, 2025 Direct F1, F2
transaction NTRA Common Stock Sale -$69.2K -400 -0.35% $173.05 114K Jan 31, 2025 Direct F3
transaction NTRA Common Stock Sale -$614K -3.5K -3.07% $175.39 111K Feb 3, 2025 Direct F3, F4
transaction NTRA Common Stock Sale -$3.03M -17.1K -15.49% $176.61 93.5K Feb 3, 2025 Direct F3, F5
transaction NTRA Common Stock Sale -$3.79M -21.4K -22.85% $177.25 72.1K Feb 3, 2025 Direct F3, F6
transaction NTRA Common Stock Sale -$267K -1.5K -2.08% $178.19 70.6K Feb 3, 2025 Direct F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on January 31, 2026 and the remaining RSUs vest in 12 equal quarterly installments thereafter.
F2 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.87 to $175.84 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.91 to $176.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.91 to $177.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.93 to $178.83 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.